Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Modelportfolio: Vi har ryddet ud i den mislykkede Aiforia-investering i porteføljen

AIFORIAResearch02.09.2026, 09.00
Juha Kinnunen, Atte Riikola, Rauli Juva
Discuss

Automatisk oversættelse: Oprindeligt udgivet på finsk 2.9.2026, 07.00 GMT. Giv feedback her.

Vi har i dag solgt Aiforia-aktierne fra Modelportfolioen, som blot havde en vægt på 1,0 %. I vores højrisikovækstinvestering udeblev væksten, hvilket ødelagde vores oprindelige investeringstesè. Vi var på købstidspunktet klar over de høje risici forbundet med Aiforia, og takket være en mindre positionsstørrelse end normalt forblev tabene i det store hele begrænsede, selvom aktien faldt med grufulde over -70 % i Modelportfolioen.

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures31.08

202526e27e
Revenue3.52.74.6
growth-%24.0 %-25.0 %75.0 %
EBIT (adj.)-11.2-13.2-10.4
EBIT-% (adj.)-316.3 %-497.3 %-224.9 %
EPS (adj.)-0.38-0.36-0.30
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Comments on the latest move LinkedIn #digitalpathology #ai #lifesciences #diagnostics | Paul Atkinson First Roche and PathAI. Now Agilent Technologies...
yesterday
by Vino Pino
16
thepathologist.com The Pathologist | Pathology Visions 2026 – Digital Pathology Conference Aiforia will also be featured there in a few days...
yesterday
by Salvelinus
11
Here are Antti’s comments regarding the acquisition of Aiforia’s partner by Agilent, a US-based laboratory and diagnostics company. The cash...
yesterday
by Sijoittaja-alokas
16
Here are Antti’s comments from when Aiforia signed the deal with PathAI. Aiforia announced on Thursday that it had entered into a commercial...
10/9/2026, 4:45 AM
by Sijoittaja-alokas
10
Kotimainen palkinto Aiforialle: Messukeskuksessa juhlittiin suomalaisia maailmanluokan tekoälyratkaisuja – Opetushallitus ja Aiforia nappasivat...
10/8/2026, 6:27 PM
by NukkeNukuttaja
16
Aiforia aloittaa yhteistyön PathAI:n kanssa laajentaakseen tekoälypohjaisen diagnostiikan saatavuutta Aiforia aloittaa yhteistyön PathAI:n kanssa...
10/8/2026, 6:09 AM
by Kulkuri
30
In my opinion, the CEO holds their own quite well in this panel. Sure, this industry is still pretty much in its infancy, but before you know...
10/1/2026, 11:52 AM
by Salvelinus
12